Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-04

Clinical Trial Update: Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults [Phase 1]

View source ↗

Summary

Phase 1 trial by Sanaria investigates controlled human malaria infection via intravenous Plasmodium falciparum sporozoites in non-immune adults; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plasmodium falciparum sporozoites (Plasmodium falciparum sporozoites)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria | Phase 1 | Status: COMPLETED